Breast CancerNCT07673588
Instagram and Podcast Intervention for Breast Cancer Awareness and Screening
A study testing Instagram-Based Breast Cancer Awareness Intervention and Instagram-Podcast-Based Breast Cancer Awareness Intervention in people with Breast Cancer and Breast Cancer Screening, run by Ankara University at 1 site in Turkey (Türkiye).
Trial summary
Breast cancer is the most common cancer among women worldwide. This randomized controlled trial aims to evaluate the effect of an Instagram- and podcast-based intervention on women's breast cancer awareness, health beliefs, and breast cancer screening behaviors among women aged 20-39 years. Read more about this study
- Who is it for?
- Ages 20 to 39 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Breast Cancer, Breast Cancer Screening
- What is being tested?
- Instagram-Based Breast Cancer Awareness Intervention and Instagram-Podcast-Based Breast Cancer Awareness Intervention
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 158 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 6 Jul 2026to 13 Oct 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 39 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Women aged 20-39 years
- Able to read and write Turkish
- Turkish citizens
- Have an active Instagram account and access it at least once daily
- No previous diagnosis of cancer
- Willing to participate and provide informed consent
Who cannot join
- No access to a smartphone with the Instagram application
- Visual, hearing, or cognitive impairment that may prevent participation in the intervention
- Withdrawal Criteria:
- Failure to complete the assigned podcast sessions during the intervention period
- Participant request to withdraw from the study at any time
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of an Instagram- and Podcast-Based Intervention on Women's Breast Cancer Awareness, Health Beliefs, and Screening Behaviors: A Randomized Controlled Trial
Breast cancer is the most common cancer among women worldwide. This randomized controlled trial aims to evaluate the effect of an Instagram- and podcast-based intervention on women's breast cancer awareness, health beliefs, and breast cancer screening behaviors among women aged 20-39 years.
Read the detailed description
Breast cancer is the most frequently diagnosed cancer among women worldwide and remains a major public health concern. Early detection through screening is essential for reducing breast cancer-related morbidity and mortality. However, many women continue to experience barriers to screening participation, including limited awareness, insufficient knowledge, low perceived susceptibility, fear of diagnosis, and inadequate health beliefs regarding breast cancer and its screening methods.
Digital health interventions have emerged as accessible and cost-effective approaches for delivering health education and promoting preventive health behaviors. Social media platforms, particularly Instagram, are widely used by young women and offer an effective channel for disseminating health-related information. Podcasts provide an additional narrative-based educational approach that may enhance engagement, improve information retention, and support behavior change through emotionally meaningful content.
This randomized controlled trial aims to evaluate the effectiveness of an Instagram- and podcast-based intervention in improving breast cancer awareness, health beliefs, and screening behaviors among women aged 20-39 years. Participants in the intervention group will receive evidence-based educational content through Instagram posts and podcasts, while the control group will receive no intervention during the study period. Outcomes will include breast cancer awareness, health beliefs related to breast cancer screening, and screening behaviors such as breast self-examination practices.
The findings of this study are expected to provide evidence regarding the effectiveness of combined social media and podcast-based interventions as scalable, low-cost strategies for promoting breast cancer awareness and encouraging preventive screening behaviors among women.
- Conditions
- Breast Cancer, Breast Cancer Screening
- Being tested
- Instagram-Based Breast Cancer Awareness Intervention, Instagram-Podcast-Based Breast Cancer Awareness Intervention
- Medical subject headings
- Breast Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Instagram-Based Breast Cancer Awareness InterventionOther
Participants will follow the "Breast Health Academy" Instagram account and receive an 8-week Instagram-based breast cancer awareness intervention. Educational breast cancer awareness and screening content will be shared as posts and stories on Mondays, Wednesdays, and Saturdays. Reminder stories encouraging breast self-examination (BSE), such as "Do not forget to perform your monthly BSE" and "Remember to perform BSE this week," will be shared on Tuesdays, Thursdays, and Sundays. Stories will also be saved as highlights. No content will be shared on Fridays, and all posts and stories will be published at the same time each day.
Instagram-Podcast-Based Breast Cancer Awareness InterventionOther
Participants will follow the "Breast Health Academy Plus" Instagram account and receive an 8-week Instagram- and podcast-based breast cancer awareness intervention. Educational breast cancer awareness and screening content will be shared as posts and stories on Mondays, Wednesdays, and Saturdays. Reminder stories encouraging breast self-examination (BSE) will be shared on Tuesdays, Thursdays, and Sundays and saved as highlights. In addition, one educational podcast episode developed for the intervention will be delivered weekly via Instagram direct message every Friday. All content will be provided at the same time each day throughout the intervention period.
| Study group | Role | What they receive |
|---|---|---|
| Instagram Group | Experimental | Participants will receive an 8-week Instagram-based breast cancer awareness intervention. Receives: Other: Instagram-Based Breast Cancer Awareness Intervention |
| Instagram + Podcast Group | Experimental | Participants will receive an 8-week Instagram- and podcast-based breast cancer awareness intervention. Receives: Other: Instagram-Podcast-Based Breast Cancer Awareness Intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Breast Cancer Awareness Scale
The Breast Cancer Awareness Measure assesses awareness of breast cancer symptoms, breast self-examination practices, and age-related risk perception. Total scores range from 0 to 3, with higher scores indicating greater breast cancer awareness.
Measured: Assessments will be performed at baseline and Week 8.
Champion's Health Belief Model Scale in Breast Cancer Screening
The Champion's Health Belief Model Scale (CHBMS) for Breast Cancer Screening is a validated instrument used to assess health beliefs related to breast cancer screening. The Turkish version consists of six subscales: perceived susceptibility (3 items), perceived seriousness (6 items), health motivation (5 items), perceived benefits of breast self-examination (BSE) (4 items), perceived barriers to BSE (8 items), and BSE self-efficacy/confidence (10 items). Each subscale is evaluated separately, and no total score is calculated. Higher scores on the perceived susceptibility, perceived seriousness, health motivation, BSE benefits, and BSE self-efficacy/confidence subscales indicate stronger health beliefs, whereas higher scores on the BSE barriers subscale indicate greater perceived barriers to breast cancer screening and breast self-examination.
Measured: Assessments will be performed at baseline and Week 8.
Secondary outcomes (2)
Breast Cancer Screening Behavior Questionnaire
Breast Cancer Screening Behavior Questionnaire. A researcher-developed 3-item questionnaire assessing breast cancer screening behaviors, including breast self-examination within the previous month, clinical breast examination by a healthcare professional, and mammography uptake or scheduling. Each item is recorded as Yes or No and analyzed separately. No total score is calculated; therefore, minimum and maximum scores are not applicable.
Measured: Assessments will be performed at baseline and Week 8.
Participant Satisfaction (VAS)
Participant satisfaction with the Instagram- and podcast-based intervention will be assessed using a 0-10 Visual Analog Scale (VAS), where 0 indicates "not satisfied at all" and 10 indicates "extremely satisfied."
Measured: Assessed at Week 8.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jun 2026
- Study start6 Jul 2026
- Primary completion6 Oct 2026
- Study completion13 Oct 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Breast CancerStudies of the same condition, open and under way.
- More trials run by Ankara UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 158 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ankara University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Baise Bicav, Ankara University
- Investigators
- Baise Bicav, Principal investigator, Yüksek İhtisas UniversityZehra Bicav, Principal investigator, Yüksek İhtisas UniversitySevinç Kutlutürkan, Study director, Ankara UniversityFiliz Ünal Toprak, Study director, Saglik Bilimleri Universitesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07673588
- Sponsor's protocol ID
- AU-HEM-BB-02
- Status last verified
- Oct 2026
- First submitted
- 23 Jun 2026
- Last updated
- 28 Oct 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of an Instagram- and Podcast-Based Intervention on Women's Breast Cancer Awareness, Health Beliefs, and Screening Behaviors: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07673588
- Acronym / sponsor ID
- AU-HEM-BB-02
- Conditions
- Breast Cancer, Breast Cancer Screening
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 158 participants (actual)
- Lead sponsor
- Ankara UniversityUniversity, hospital or other
- Study start
- 6 Jul 2026 (actual)
- Primary completion
- 6 Oct 2026 (actual)
- Study completion
- 13 Oct 2026 (actual)
- First posted
- 29 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Breast cancer is the most common cancer among women worldwide. This randomized controlled trial aims to evaluate the effect of an Instagram- and podcast-based intervention on women's breast cancer awareness, health beliefs, and breast cancer screening behaviors among women aged 20-39 years.
Detailed description
Breast cancer is the most frequently diagnosed cancer among women worldwide and remains a major public health concern. Early detection through screening is essential for reducing breast cancer-related morbidity and mortality. However, many women continue to experience barriers to screening participation, including limited awareness, insufficient knowledge, low perceived susceptibility, fear of diagnosis, and inadequate health beliefs regarding breast cancer and its screening methods.
Digital health interventions have emerged as accessible and cost-effective approaches for delivering health education and promoting preventive health behaviors. Social media platforms, particularly Instagram, are widely used by young women and offer an effective channel for disseminating health-related information. Podcasts provide an additional narrative-based educational approach that may enhance engagement, improve information retention, and support behavior change through emotionally meaningful content.
This randomized controlled trial aims to evaluate the effectiveness of an Instagram- and podcast-based intervention in improving breast cancer awareness, health beliefs, and screening behaviors among women aged 20-39 years. Participants in the intervention group will receive evidence-based educational content through Instagram posts and podcasts, while the control group will receive no intervention during the study period. Outcomes will include breast cancer awareness, health beliefs related to breast cancer screening, and screening behaviors such as breast self-examination practices.
The findings of this study are expected to provide evidence regarding the effectiveness of combined social media and podcast-based interventions as scalable, low-cost strategies for promoting breast cancer awareness and encouraging preventive screening behaviors among women.
Study design
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Instagram Group | Experimental | Other: Instagram-Based Breast Cancer Awareness InterventionParticipants will receive an 8-week Instagram-based breast cancer awareness intervention. |
| Instagram + Podcast Group | Experimental | Other: Instagram-Podcast-Based Breast Cancer Awareness InterventionParticipants will receive an 8-week Instagram- and podcast-based breast cancer awareness intervention. |
Who may qualify
- Ages
- 20 to 39 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (6 listed)
- Women aged 20-39 years
- Able to read and write Turkish
- Turkish citizens
- Have an active Instagram account and access it at least once daily
- No previous diagnosis of cancer
Key exclusion criteria (5 listed)
- No access to a smartphone with the Instagram application
- Visual, hearing, or cognitive impairment that may prevent participation in the intervention
- Failure to complete the assigned podcast sessions during the intervention period
- Participant request to withdraw from the study at any time
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Instagram-Based Breast Cancer Awareness InterventionParticipants will follow the "Breast Health Academy" Instagram account and receive an 8-week Instagram-based breast cancer awareness intervention. Educational breast cancer awareness and screening content will be shared as posts and stories on Mondays, Wednesdays, and Saturdays. Reminder stories encouraging breast self-examination (BSE), such as "Do not forget to perform your monthly BSE" and "Remember to perform BSE this week," will be shared on Tuesdays, Thursdays, and Sundays. Stories will also be saved as highlights. No content will be shared on Fridays, and all posts and stories will be published at the same time each day. | Other | Instagram Group |
| Instagram-Podcast-Based Breast Cancer Awareness InterventionParticipants will follow the "Breast Health Academy Plus" Instagram account and receive an 8-week Instagram- and podcast-based breast cancer awareness intervention. Educational breast cancer awareness and screening content will be shared as posts and stories on Mondays, Wednesdays, and Saturdays. Reminder stories encouraging breast self-examination (BSE) will be shared on Tuesdays, Thursdays, and Sundays and saved as highlights. In addition, one educational podcast episode developed for the intervention will be delivered weekly via Instagram direct message every Friday. All content will be provided at the same time each day throughout the intervention period. | Other | Instagram + Podcast Group |
Primary outcome
Breast Cancer Awareness Scale
Time frame: Assessments will be performed at baseline and Week 8.
The Breast Cancer Awareness Measure assesses awareness of breast cancer symptoms, breast self-examination practices, and age-related risk perception. Total scores range from 0 to 3, with higher scores indicating greater breast cancer awareness.
Champion's Health Belief Model Scale in Breast Cancer Screening
Time frame: Assessments will be performed at baseline and Week 8.
The Champion's Health Belief Model Scale (CHBMS) for Breast Cancer Screening is a validated instrument used to assess health beliefs related to breast cancer screening. The Turkish version consists of six subscales: perceived susceptibility (3 items), perceived seriousness (6 items), health motivation (5 items), perceived benefits of breast self-examination (BSE) (4 items), perceived barriers to BSE (8 items), and BSE self-efficacy/confidence (10 items). Each subscale is evaluated separately, and no total score is calculated. Higher scores on the perceived susceptibility, perceived seriousness, health motivation, BSE benefits, and BSE self-efficacy/confidence subscales indicate stronger health beliefs, whereas higher scores on the BSE barriers subscale indicate greater perceived barriers to breast cancer screening and breast self-examination.
2 secondary outcomes
Breast Cancer Screening Behavior Questionnaire
Time frame: Assessments will be performed at baseline and Week 8.
Participant Satisfaction (VAS)
Time frame: Assessed at Week 8.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Breast Cancer
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Not yet recruitingObservational study
Comparison of Reliability, Time Cost, and Participant Comfort of Lymphedema Assessments in Upper Extremity
Lymphedema, Upper Extremity Lymphedema
RecruitingPhase 3
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
TNBC - Triple-Negative Breast Cancer
RecruitingPhase 3
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Baise Bicav principal investigator
Yüksek İhtisas University
Zehra Bicav principal investigator
Yüksek İhtisas University
Sevinç Kutlutürkan study director
Ankara University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Instagram-Based Breast Cancer Awareness Intervention and Instagram-Podcast-Based Breast Cancer Awareness Intervention in people with Breast Cancer and Breast Cancer Screening, run by Ankara University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Breast Cancer Awareness Scale (time frame: Assessments will be performed at baseline and Week 8.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2026.